OpenAI acquires Orchestra Bio Post published: 2026-10-21 OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments. Read more articles Previous PostMPS in PyTorch 2.15 Next PostFranchisee reconciles cash in 94% less time with ChatGPT Work